Pfizer Inc. and German partner BioNTech SA said on Friday they have started an application process with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccine, currently only authorized for emergency use. If approved, the vaccine …
Texas nurse Jennifer Bridges plans to go to work on June 7, like it’s any other day. The only difference is, when she gets there she expects to be fired. That day is the deadline her employer, Houston Methodist hospital, …
Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region’s medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots. Europe’s health regulator, …
JOHANNESBURG – The South African government’s compensation fund to cover potential injuries from COVID-19 vaccines could cost around 250 million rand ($17.5 million) in the first year, the health minister said in response to questions in parliament. The African country …
The risk of being exposed to the COVID-19 virus on an airline flight drops by as much as half when airlines keep middle seats open, a new study published by the U.S. government concludes, a safety practice the carriers have …
International Business Machines Corp. said on Wednesday its cyber-security unit has uncovered more digital attacks targeting the global COVID-19 vaccine supply chain since the issue was originally flagged late last year. The cloud services provider said it recently found that …
U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to …
AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publicly criticized the drugmaker for using “outdated information” to show how well the immunization worked. The rare public rebuke marks the latest …
AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once …
The U.S. will reach herd immunity threshold when more than 71% of the U.S. population has been exposed to COVID or effectively vaccinated against it, most likely by mid-summer, says a management consultant firm that has been tracking COVID cases. …
